Trials / Conditions / Ovarian Cancer Metastatic
Ovarian Cancer Metastatic
4 registered clinical trials studyying Ovarian Cancer Metastatic — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expres NCT07311577 | Jiangsu Cancer Institute & Hospital | Phase 2 |
| Recruiting | Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants W NCT07444814 | Whitehawk Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | O-RADS MRI System on Early Detection of Ovarian Cancer NCT07009743 | Shanghai Gynecologic Oncology Group | — |
| Withdrawn | OVSTAR TIL Trial (OVarian Cancer Co-STimulatory Antigen Receptor TIL Trial) NCT04389229 | Immetacyte Ltd | Phase 1 / Phase 2 |